298. 遺伝性膵炎 Disease details / Clinical trials / Drug dev / DR info

98% dehydrated alcohol
   Indiana University
      2002   -   NCT00583271   United States
A04ad10
   Radboud University Nijmegen Medical Centre
      2012   Phase 2   EUCTR2012-000730-19-NL   Netherlands
      2011   -   EUCTR2011-000647-24-NL   Netherlands
Acarbose
   Changhai Hospital
      2022   -   NCT05261997   China
Acetyl-L-carnitine 1000MG 2X PER DAY FOR 3 months
   Karin High
      2015   Early Phase 1   NCT02538146   United States
Acetylcysteine
   POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
      2012   -   EUCTR2012-004170-26-IT   Italy
Alanine
   Meridian Bioscience, Inc.
      2009   Phase 2   NCT01259544   India
Alpha 1-antitrypsin
   University of Minnesota
      2016   Phase 4   NCT02713997   United States
Amino acids
   Tohoku University Hospital
      2010   -   JPRN-UMIN000003020   Japan
Amlodipine
   University of Pittsburgh
      2005   Phase 1/Phase 2   NCT00156403   United States
Analgesics
   Changhai Hospital
      2025   -   NCT05270434   China
      2016   -   NCT02971475   China
Antioxidant plus pregabalin
   Asian Institute of Gastroenterology, India
      2012   -   NCT01528540   India
Antioxidants
   All India Institute of Medical Sciences, New Delhi
      2003   Phase 3   NCT00319358   India
Antox (vers) 1.2
   University of Liverpool
      2008   Phase 3   EUCTR2006-000087-83-GB   United Kingdom
Antox (vers.)1.2
   University Medicine Greifswald
      2005   Phase 3   NCT00142233   Germany
Antox version 1.2
   Pharmanord, UK, LTD
      2007   Phase 2   EUCTR2006-006958-10-GB   United Kingdom
Ascorbic acid
   University of Liverpool
      2008   Phase 3   EUCTR2006-000087-83-GB   United Kingdom
Autologous mesenchymal stromal cell
   Medical University of South Carolina
      2014   Phase 1   NCT02384018   United States
Bone marrow-derived mesenchymal stem cells
   Medical University of South Carolina
      2021   Phase 1   NCT05095532   United States
Bupivicaine alone
   The Cleveland Clinic
      2008   Phase 3   NCT00658736   United States
Buprenorphine
   Changhai Hospital
      2025   -   NCT05270434   China
Calcium, dietary
   Hvidovre University Hospital
      2009   -   NCT01141998   Denmark
Carbon monoxide-bubbled mediums
   Medical University of South Carolina
      2015   Phase 1/Phase 2   NCT02567240   United States
Celiac block with triamcinolone and bupivicaine
   University of Southern California
      2014   -   NCT02399800   United States
Cholecalciferol
   Hvidovre University Hospital
      2009   -   NCT01141998   Denmark
Continuous glucose monitor
   Changhai Hospital
      2023   -   NCT05989867   China
Creon
   AbbVie
      2021   Phase 4   NCT05069597   United States
      2021   -   NCT04949828   United States
      2020   Phase 4   NCT04315311   United States
   Hospital Avicenne
      2004   Phase 4   NCT00957151   France
   Institut National de la Recherche Agronomique
      2005   -   NCT01154608   France
Creon 10000
   Solvay Pharmaceuticals GmbH
      2008   -   EUCTR2007-004004-12-BG   Bulgaria
Creon 25000
   Department of gastroenterology. University Hospital of Santiago
      2016   -   EUCTR2015-002570-20-ES   Spain
   Solvay Pharmaceuticals GmbH
      2008   -   EUCTR2007-004004-12-BG   Bulgaria
Diazepam
   Radboud University
      2011   Phase 2   NCT01318369   Netherlands
Dronabinol
   Radboud University Nijmegen Medical Centre
      2012   Phase 2   EUCTR2012-000730-19-NL   Netherlands
      2011   -   EUCTR2011-000647-24-NL   Netherlands
Empagliflozin
   Mayo Clinic
      2025   Phase 2   NCT06729996   United States
Endoscopic drainage OF THE main pancreatic duct
   Changhai Hospital
      2016   -   NCT02971475   China
Endoscopy FOR pancreatic function testing
   Mayo Clinic
      2020   Phase 1/Phase 2   NCT04207060   United States
Ensure surgical
   Ohio State University
      2017   -   NCT03244683   United States
Ercp with bupivacaine infusion
   Johns Hopkins University
      2021   Early Phase 1   NCT04611958   United States
Esomeprazole
   University of Florida
      2009   Phase 1   NCT01142128   United States
Etanercept
   University of Minnesota
      2016   Phase 4   NCT02713997   United States
EUR-1008 (APT-1008) high dose
   Forest Laboratories
      2008   Phase 3   NCT00788593   Italy;Ukraine;United States
EUR-1008 (APT-1008) LOW dose
   Forest Laboratories
      2008   Phase 3   NCT00788593   Italy;Ukraine;United States
EUR-1066-A
   Forest Laboratories
      2010   Phase 1   NCT01159119   United States
EUR-1066-B
   Forest Laboratories
      2010   Phase 1   NCT01159119   United States
EUS procedure with drug injection
   Centre hospitalier de l'Université de Montréal (CHUM)
      2011   Phase 3   NCT01318590   Belgium;Canada
Extracorporeal shock wave lithotripsy
   Changhai Hospital
      2016   -   NCT02971475   China
Extracorporeal shock wave lithotripsy and endoscopic drainage OF THE main pancreatic duct
   Changhai Hospital
      2022   -   NCT05261997   China
Fentanyl
   Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine
      2023   Phase 1   ChiCTR2300074473   China
Fluimucil*20CPR EFF 600MG
   POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
      2012   -   EUCTR2012-004170-26-IT   Italy
Gabapentin prescriptions
   GlaxoSmithKline
      2010   -   NCT01236053   -
      2010   -   NCT01138124   -
Genetic sequencing
   Changhai Hospital
      2011   -   NCT04574297   -
Human secretin
   ChiRhoClin, Inc.
      2010   Phase 1/Phase 2   NCT01265875   United States
   Massachusetts General Hospital
      2008   Phase 1   NCT00621283   United States
      2008   Phase 1   NCT00620919   United States
Hydroxychloroquine
   The Cleveland Clinic
      2017   Phase 2   NCT03283566   United States
Indomethacin
   Mayo Clinic
      2020   Phase 1/Phase 2   NCT04207060   United States
Intra plexus triamcinolone and bupivicaine injection
   University of Southern California
      2014   -   NCT02399800   United States
Kreon 25000
   Department of gastroenterology. University Hospital of Santiago
      2016   -   EUCTR2015-002570-20-ES   Spain
Laboratory biomarker analysis
   National Cancer Institute (NCI)
      2016   Phase 2   NCT02743364   United States
Lacosamide
   Indiana University
      2023   Phase 1   NCT05603702   United States
Lanreotide acetate
   Erasme hospital
      2010   Phase 2   EUCTR2009-016082-29-BE   Belgium
Lidocaine IV
   Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
      2021   Phase 2   NCT05906615   Netherlands
Lipase
   Axcan Pharma S.A.
      2004   -   EUCTR2004-002468-89-DE   Germany
   Berlin-Chemie AG
      2010   -   EUCTR2005-000562-38-DE   Germany
      2005   -   EUCTR2005-000736-24-DE   Germany
   EURAND SPA
      2008   -   EUCTR2008-000061-37-IT   Italy
   Erasmus MC
      2011   -   EUCTR2010-020303-69-NL   Netherlands
Liprotamase
   Anthera Pharmaceuticals
      2007   Phase 3   NCT00500084   United States
LOW-intensity exercise therapy
   Ohio State University
      2017   -   NCT03244683   United States
Lyrica
   Afdeling heelkunde, Universitair Medisch Centrum Sint Radboud
      2009   Phase 4   EUCTR2009-010266-28-NL   Netherlands
   Department of Medical Gastroenterology
      2008   Phase 3   EUCTR2008-002671-27-DK   Denmark
Magnesiocard 2.5mmol
   University of Liverpool
      2008   Phase 3   EUCTR2006-000087-83-GB   United Kingdom
Magnesium
   University Medicine Greifswald
      2005   Phase 3   NCT00142233   Germany
   University of Florida
      2009   Phase 1   NCT01142128   United States
Magnesium aspartate hydrochloride
   University of Liverpool
      2008   Phase 3   EUCTR2006-000087-83-GB   United Kingdom
Mayo interactive breath hold monitor
   Mayo Clinic
      2006   -   NCT00588367   United States
Mesenchymal stem cells
   Medical University of South Carolina
      2024   Early Phase 1   NCT06205342   United States
   VA Office of Research and Development
      2024   Phase 1   NCT05925036   United States
Metamizole
   Changhai Hospital
      2025   -   NCT05270434   China
Metformin
   Changhai Hospital
      2025   Phase 4   NCT06937294   China
Methionine
   University of Liverpool
      2008   Phase 3   EUCTR2006-000087-83-GB   United Kingdom
Mezym F
   Berlin-Chemie AG
      2010   -   EUCTR2005-000562-38-DE   Germany
Midazolam
   Prof. Asbjørn Mohr Drewes
      2013   Phase 4   EUCTR2013-003357-17-DK   Denmark
Morphine
   Changhai Hospital
      2025   -   NCT05270434   China
MS1819
   Laboratoires Mayoly Spindler
      2010   -   EUCTR2010-018900-10-FR   France
MS1819-SD
   AzurRx SAS
      2017   Phase 2   NCT03481803   Australia;France;New Zealand
Namisol
   Radboud University
      2011   Phase 2   NCT01318369   Netherlands
   Radboud University Nijmegen Medical Centre
      2012   Phase 2   EUCTR2012-000730-19-NL   Netherlands
      2011   -   EUCTR2011-000647-24-NL   Netherlands
NI-03
   Kangen Pharmaceuticals, Inc
      2016   Phase 1/Phase 2   NCT02693093   Russian Federation;Ukraine;United States
NO enzyme therapy
   Institut National de la Recherche Agronomique
      2005   -   NCT01154608   France
NON-enteric coated pancreatic enzyme preparation
   Asian Institute of Gastroenterology, India
      2021   -   NCT05042284   India
Nutrition counseling
   Ohio State University
      2017   -   NCT03244683   United States
Omeprazole
   Forest Laboratories
      2007   Phase 3   NCT00559364   Canada;Germany;Poland;Slovakia;United States
Oxycodone
   Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine
      2023   Phase 1   ChiCTR2300074473   China
Oxycodone depot ”sandoz”, depot tablets
   Mech-Sense, Dept. Gastroenterology & Hepatology, Aalborg University Hospital
      2017   Phase 1;Phase 4   EUCTR2017-000732-34-DK   Denmark
Oxycodone hydrochloride
   Mech-Sense, Dept. Gastroenterology & Hepatology, Aalborg University Hospital
      2017   Phase 1;Phase 4   EUCTR2017-000732-34-DK   Denmark
Oxycodonhydrochlorid ”lannacher”, depot tablets
   Mech-Sense, Dept. Gastroenterology & Hepatology, Aalborg University Hospital
      2017   Phase 1;Phase 4   EUCTR2017-000732-34-DK   Denmark
Oxygen
   ShangHai ChangHai Hospital
      2024   -   ChiCTR2400093743   China
Oxynorm
   Mech-Sense, Dept. Gastroenterology & Hepatology, Aalborg University Hospital
      2017   Phase 1;Phase 4   EUCTR2017-000732-34-DK   Denmark
Pancreatic enzymes
   Erasmus MC
      2011   -   EUCTR2010-020303-69-NL   Netherlands
Pancreatin
   Abbott Products
      2008   Phase 3   NCT00705978   India
   Axcan Pharma S.A.
      2004   -   EUCTR2004-002468-89-DE   Germany
   Berlin-Chemie AG
      2010   -   EUCTR2005-000562-38-DE   Germany
      2005   -   EUCTR2005-000736-24-DE   Germany
   Changhai Hospital
      2022   -   NCT05261997   China
Pancrelipase
   Dartmouth-Hitchcock Medical Center
      2016   Phase 2   NCT02706236   United States
   Department of Internal Medicine Second Teaching Hospital Fujita Health University School of Medicine
      2012   -   JPRN-UMIN000009547   Japan
   Digestive Care, Inc.
      2008   Phase 4   NCT00744250   United States
   Fukushima Medical University Aizu Medical Center
      2013   -   JPRN-UMIN000013182   Japan
Pancrelipase delayed release capsule
   Solvay Pharmaceuticals
      2007   Phase 3   NCT00414908   Bulgaria;Former Serbia and Montenegro;Poland;Puerto Rico;Russian Federation;Serbia;South Africa;Ukraine;United States
   Solvay Pharmaceuticals GmbH
      2008   -   EUCTR2007-004004-12-BG   Bulgaria
Pancrelipase/pancreas powder
   Solvay Pharmaceuticals GmbH
      2008   -   EUCTR2007-004004-12-BG   Bulgaria
Panzytrat
   Erasmus MC
      2011   -   EUCTR2010-020303-69-NL   Netherlands
Panzytrat 25.000
   Axcan Pharma S.A.
      2004   -   EUCTR2004-002468-89-DE   Germany
Panzytrat 25.000 FIP-E units OF lipase
   Foundation for Liver Research
      2011   Phase 4   NCT01430234   Netherlands
Paricalcitol
   Cedars-Sinai Medical Center
      2023   Early Phase 1   NCT05664880   United States
Pentoxifylline
   Mayo Clinic
      2015   Phase 3   NCT02487225   United States
Perflubutane
   Department of Endoscopy The Jikei University School of Medicine
      2018   -   JPRN-UMIN000030735   Japan
Pethidine
   Changhai Hospital
      2025   -   NCT05270434   China
Pharmacologic approaches TO glycemic treatment
   Changhai Hospital
      2021   -   NCT05764629   China
Pinaverium bromide
   Yanqing Li
      2025   -   NCT06936800   China
Pioglitazone
   Mayo Clinic
      2025   Phase 2   NCT06729996   United States
   University of Michigan
      2008   Phase 2   NCT00782795   United States
PL 00512/0150
   Department of gastroenterology. University Hospital of Santiago
      2016   -   EUCTR2015-002570-20-ES   Spain
Pregabalin
   Aalborg Universitetshospital
      2008   Phase 2/Phase 3   NCT00755573   Denmark;Netherlands
   Department of Medical Gastroenterology
      2008   Phase 3   EUCTR2008-002671-27-DK   Denmark
Proglumide
   Georgetown University
      2022   Phase 1/Phase 2   NCT05551858   United States
Prolastin-C
   Medical University of South Carolina
      2017   Phase 1/Phase 2   NCT02947087   United States
Proteolytic enzyme fortified protein supplement
   Asian Institute of Gastroenterology, India
      2024   -   NCT06585735   India
Quality-OF-life assessment
   National Cancer Institute (NCI)
      2016   Phase 2   NCT02743364   United States
Questionnaire administration
   National Cancer Institute (NCI)
      2016   Phase 2   NCT02743364   United States
Recombinant microbial lipase
   Solvay Pharmaceuticals GmbH
      2008   -   EUCTR2007-000375-42-LV   Czech Republic;Denmark;Hungary;Latvia;Sweden
      2008   -   EUCTR2007-000375-42-HU   Czech Republic;Denmark;Hungary;Latvia;Sweden
      2008   -   EUCTR2007-000375-42-DK   Czech Republic;Denmark;Hungary;Latvia;Sweden
      2008   -   EUCTR2007-000375-42-CZ   Czech Republic;Denmark;Hungary;Latvia;Sweden
      2007   -   EUCTR2007-000375-42-SE   Czech Republic;Denmark;Hungary;Latvia;Sweden
Recombinant microbial lipase SLV339
   Solvay Pharmaceuticals
      2008   Phase 2   NCT00630279   Czech Republic;Denmark;Hungary;Latvia;Poland;Russian Federation;Sweden
REGN475/SAR164877
   Regeneron Pharmaceuticals
      2009   Phase 2   NCT01001923   United States
Reparixin
   Dompé Farmaceutici S.p.A
      2014   Phase 2/Phase 3   NCT01967888   Canada;United States
RVG 13760
   Erasmus MC
      2011   -   EUCTR2010-020303-69-NL   Netherlands
S-ketamin
   Prof. Asbjørn Mohr Drewes
      2013   Phase 4   EUCTR2013-003357-17-DK   Denmark
SA-001
   Abbott
      2008   Phase 3   NCT00401076   Japan
      2007   Phase 3   NCT00400842   Japan
Secretin
   Children's Hospital Medical Center, Cincinnati
      2016   -   NCT02869893   United States
   University of Nottingham
      2012   Phase 1/Phase 2   NCT02458118   United Kingdom
      2010   Phase 1   NCT01452217   United Kingdom
Selenium
   University of Liverpool
      2008   Phase 3   EUCTR2006-000087-83-GB   United Kingdom
Simvastatin
   Cedars-Sinai Medical Center
      2024   Early Phase 1   NCT05771675   United States
   National Cancer Institute (NCI)
      2016   Phase 2   NCT02743364   United States
SLV339
   Solvay Pharmaceuticals GmbH
      2008   -   EUCTR2007-000375-42-LV   Czech Republic;Denmark;Hungary;Latvia;Sweden
      2008   -   EUCTR2007-000375-42-HU   Czech Republic;Denmark;Hungary;Latvia;Sweden
      2008   -   EUCTR2007-000375-42-DK   Czech Republic;Denmark;Hungary;Latvia;Sweden
      2008   -   EUCTR2007-000375-42-CZ   Czech Republic;Denmark;Hungary;Latvia;Sweden
      2007   -   EUCTR2007-000375-42-SE   Czech Republic;Denmark;Hungary;Latvia;Sweden
Smoking and alcohol assumption
   Changhai Hospital
      2011   -   NCT04574297   -
Sodium chloride 0.9% INJ
   Soren Schou Olesen
      2024   Phase 2   NCT06426160   Denmark
Somatuline autogel 90 MG
   Erasme hospital
      2010   Phase 2   EUCTR2009-016082-29-BE   Belgium
SOY bread
   Ohio State University
      2015   -   NCT02577640   United States
Tanezumab
   Pfizer
      2010   Phase 2   NCT01146561   United States
Tetrahydro-6,6,9-TRI methyl-3-penthyl-6 H-dibenzo[ B,D ]pyran-1-OL
   Radboud University Nijmegen Medical Centre
      2012   Phase 2   EUCTR2012-000730-19-NL   Netherlands
Tetrahydrocannabinol
   Radboud University
      2012   Phase 2   NCT01551511   Netherlands
Thalidomide
   Winthrop University Hospital
      2005   Phase 2   NCT00469703   United States
Time interval between eswl and ercp IS 12H
   Changhai Hospital
      2025   -   NCT05270434   China
Time interval between eswl and ercp IS greater than 12H
   Changhai Hospital
      2025   -   NCT05270434   China
Tocilizumab
   Soren Schou Olesen
      2024   Phase 2   NCT06426160   Denmark
Tocopherol
   University of Liverpool
      2008   Phase 3   EUCTR2006-000087-83-GB   United Kingdom
Triamcinolone
   Indiana University
      2002   -   NCT00583271   United States
   The Cleveland Clinic
      2008   Phase 3   NCT00658736   United States
TYR
   Meridian Bioscience, Inc.
      2009   Phase 2   NCT01259544   India
UVB
   Hvidovre University Hospital
      2009   -   NCT01141998   Denmark
Viokase 16
   Axcan Pharma
      2008   Phase 2   NCT00559052   Czech Republic;United States
Viokase 16 (pancrelipase) + nexium
   University of Florida
      2009   Phase 1   NCT01142128   United States
Viokase® 16
   Forest Laboratories
      2007   Phase 3   NCT00559364   Canada;Germany;Poland;Slovakia;United States
Vitamin D 100UG
   Tampere University Hospital
      2016   -   NCT02965898   Finland
Vitamin D 10UG
   Tampere University Hospital
      2016   -   NCT02965898   Finland
Yarrowia lipolytica lipase
   Laboratoires Mayoly Spindler
      2010   -   EUCTR2010-018900-10-FR   France
Zenpep
   Forest Laboratories
      2010   Phase 1   NCT01159119   United States
Zentase
   EURAND SPA
      2008   -   EUCTR2008-000061-37-IT   Italy